October 9, 2014 Capricor Therapeutics Announces Plans to Pursue a Cenderitide Clinical Program and Enters Into Research Support Agreement With Insulet Corporation
October 6, 2014 Capricor Announces Plans to Pursue Clinical Program for the Treatment of Duchenne Muscular Dystrophy With Cardiosphere-Derived Cells (CDCs)
September 18, 2014 Capricor Presents Safety and Preliminary Efficacy Results From ALLSTAR Phase I Clinical Trial at TCT 2014
September 16, 2014 Kite Pharma to Present at the 21st Annual NewsMakers in the Biotech Industry Investment Conference on Friday, September 26
August 26, 2014 Kite Pharma to Present at the Citi 9th Annual Biotech Conference on Wednesday, September 3
August 25, 2014 Kite Pharma Announces Patients With Aggressive Non-Hodgkin’s Lymphoma Experience Positive Results After Receiving Anti-CD19 Chimeric Antigen Receptor (CAR) T Cells at the National Cancer Institute (NCI)
August 4, 2014 Capricor Therapeutics to Hold Second Quarter 2014 Business Update Conference Call on August 13, 2014 at 4:30 p.m. Eastern Time
July 18, 2014 Arno Therapeutics, Inc. Appoints Alexander Zukiwski, M.D. as Interim Chief Executive Officer and Mr. Lawrence Kenyon as Chief Operating Officer
July 16, 2014 Capricor Announces Encouraging Results From Phase I ALLSTAR Trial; Phase II Trial Underway
June 23, 2014 Kite Pharma Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares
June 23, 2014 Capricor Therapeutics to Present at the First Regenerative Medicine Forum at BIO International Convention
June 19, 2014 Capricor Therapeutics Speaks at Panel on Regulation of Stem Cell-Derived Therapeutic Products at DIA 2014 50th Annual Meeting
May 28, 2014 Capricor Therapeutics to Present on Exosomes as a Basis for Innovative Platform Technology at 11th International Symposium on Stem Cell Therapy and Cardiovascular Innovations
May 14, 2014 Arno Therapeutics to Outline Two Phase I Studies Evaluating Onapristone in Men’s and Women’s Cancers at 2014 ASCO Annual Meeting
